Supplementary Figure 4: WEE1 has functional significance in HUVECs. a. Example images of Hoechst staining of HUVECs
72 hrs after transfection with scrambled siRNA (Scr) or with siGENOME WEE1 siRNA (siWEE1A) as part of an RNA interference initial screen. Scale bars 50 μm. b. Further example images validating the RNA interference initial screen findings in (a). Here, ON-TARGETplus WEE1 siRNA (siWEE1B) has been used. Scale bars 50 μm. c. On the left, Western blot labelled with anti-WEE1 and anti-β-Actin antibodies for non-transfected (NT) HUVECs and HUVECs transfected with scrambled siRNA (Scr) or ON-TARGETplus WEE1-targeted siRNA (siWEE1). On the right, quantification of the WEE1 band intensity for the siWEE1 group normalised to the Scr group (n=3 each). d. On the left, Western blot labelled with anti-pCDK1-Y15, anti-CDK1 and anti-β-Actin antibodies for non-transfected (NT) HUVECs and HUVECs transfected with scrambled siRNA (Scr) or WEE1-targeted siRNA (siWEE1). On the right, quantification of the pCDK1-Y15 band intensity divided by the CDK1 intensity (n=3 each). e. On the left, fluorescence images of HUVECs 48 hr after transfection with scrambled (Scr) or WEE1 siRNA (siWEE1). Fluorescence was from cell nuclei stained with Vybrant® Dye Cycle™ (green). Scale bars 400 μm. On the right, normalised quantification of the images from independent repeats (n=3, N=18). f. Mean data for HUVEC viability measured using WST-1 reagent after treatment with AZD1775 at the indicated concentrations and plotted as percentages of the vehicle control (n=3, N=9). g. On the left, example linear wound mask images after 24 hr HUVEC migration in vehicle control (Control) or 1 µM AZD1775. Black represents cells outside the linear wound (top to bottom), grey -cells which had migrated into the wound, and white -no cells. Scale bars 200 μm. On the right, mean data from images of the type shown on the left. Relative wound density (RWD) in the presence of AZD1775 is presented as a percentage of Control (n=3, N=12).
